Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19.

Fumihiro OgawaYasufumi OiKento NakajimaReo MatsumuraTomoki NakagawaTakao MiyagawaKazuya SakaiRyo SajiHayato TaniguchiKohei TakahashiTakeru AbeMasayuki IwashitaMototsugu NishiiIchiro Takeuchi

Published in: Thrombosis journal (2021)

Temporal change of SDC-1 levels closely reflect the severity of COVID-19, therefore, SDC-1 may be a therapeutic target and a biomarker for the severity classification of Covid-19.

Keyphrases

coronavirus disease
sars cov
machine learning
deep learning
respiratory syndrome coronavirus